<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Midlife Health</journal-id><journal-id journal-id-type="iso-abbrev">J Midlife Health</journal-id><journal-id journal-id-type="pmc-domain-id">1548</journal-id><journal-id journal-id-type="pmc-domain">jmidhlth</journal-id><journal-id journal-id-type="publisher-id">JMH</journal-id><journal-id journal-id-type="publisher-id">J Mid-life Health</journal-id><journal-title-group><journal-title>Journal of Mid-Life Health</journal-title></journal-title-group><issn pub-type="ppub">0976-7800</issn><issn pub-type="epub">0976-7819</issn><publisher><publisher-name>Wolters Kluwer -- Medknow Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12431711</article-id><article-id pub-id-type="pmcid-ver">PMC12431711.1</article-id><article-id pub-id-type="pmcaid">12431711</article-id><article-id pub-id-type="pmcaiid">12431711</article-id><article-id pub-id-type="doi">10.4103/jmh.jmh_106_25</article-id><article-id pub-id-type="publisher-id">JMH-16-301</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison of Postoperative Urinary Storage Function Following Laparoscopic Sacrocolpopexy and Transvaginal Mesh Surgery Using Nearest-neighbor Propensity Score Matching Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kuroda</surname><given-names initials="K">Kenji</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hamamoto</surname><given-names initials="K">Koetsu</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kawamura</surname><given-names initials="K">Kazuki</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Masunaga</surname><given-names initials="A">Ayako</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names initials="H">Hiroaki</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ito</surname><given-names initials="K">Keiichi</given-names></name><xref rid="aff1" ref-type="aff"/></contrib></contrib-group><aff id="aff1">Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan</aff><author-notes><corresp id="cor1"><bold><italic toggle="yes">Address for correspondence:</italic></bold> Dr. Kenji Kuroda, Department of Urology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, Japan. E-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ndmcwomensurology@gmail.com">ndmcwomensurology@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2025</year></pub-date><pub-date pub-type="epub"><day>05</day><month>9</month><year>2025</year></pub-date><volume>16</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">496819</issue-id><fpage>301</fpage><lpage>308</lpage><history><date date-type="received"><day>08</day><month>5</month><year>2025</year></date><date date-type="rev-recd"><day>05</day><month>6</month><year>2025</year></date><date date-type="accepted"><day>25</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright: &#169; 2025 Journal of Mid-life Health</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JMH-16-301.pdf"/><abstract><title>A<sc>BSTRACT</sc></title><sec><title>Objectives:</title><p>Laparoscopic sacrocolpopexy (LSC) and transvaginal mesh surgery (TVM) have been shown to effectively treat pelvic organ prolapse (POP). However, their effects on urinary incontinence (UI) remain unknown, particularly when conducted on patient groups with similar backgrounds. We here aimed to compare the postoperative UI-related symptoms between patient groups without preoperative statistical differences.</p></sec><sec><title>Materials and Methods:</title><p>We retrospectively evaluated 243 patients with POP who underwent LSC or TVM at our hospital. Ninety-six patients were treated by LSC, whereas 147 were treated by TVM. After using nearest-neighbor propensity score matching, we compared the postoperative UI-related symptoms between the matched 67 LSC-treated patients and 67 TVM-treated patients.</p></sec><sec><title>Results:</title><p>Following propensity score matching, the matched LSC and TVM groups did not demonstrate significant differences in terms of the explanatory factors. In both matched groups, the overactive bladder symptom score (OABSS) and International Consultation on Incontinence Questionnaire Short-Form (ICIQ-SF) score were significantly decreased at 3&#8211;12 months postoperatively compared with preoperative variables. The 60-min pad weight test revealed a significant decrease in the LSC and TVM groups at 12 months postoperatively. When comparing the results at 1 year postoperatively with preoperative values, the matched LSC and TVM groups demonstrated no significant differences in changes of the 60-min pad weight, OABSS, and ICIQ-SF score.</p></sec><sec><title>Conclusion:</title><p>TVM appears to be a more favorable option for managing all types of POP than LSC, considering its shorter operative time and lower complication rate, as shown using nearest-neighbor propensity score matching analysis.</p></sec></abstract><kwd-group><title>K<sc>EYWORDS:</sc></title><kwd><italic toggle="yes">Laparoscopic sacrocolpopexy</italic></kwd><kwd><italic toggle="yes">nearest-neighbor propensity score matching</italic></kwd><kwd><italic toggle="yes">pelvic organ prolapse</italic></kwd><kwd><italic toggle="yes">transvaginal mesh surgery</italic></kwd><kwd><italic toggle="yes">urinary incontinence</italic></kwd></kwd-group><funding-group><funding-statement>
Nil.
</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>I<sc>NTRODUCTION</sc></title><p>The International Urogynecological Association and International Continence Society have defined pelvic organ prolapse (POP) as a deviation from a female&#8217;s normal sensation, structure, or function with reference to the position of her pelvic organs.[<xref rid="R1" ref-type="bibr">1</xref>] Globally, prevalence rates range from 9% to 20%, and they are higher when POP is diagnosed through vaginal examination as opposed to symptom-based diagnosis.[<xref rid="R2" ref-type="bibr">2</xref>] POP symptoms encompass vaginal bulge, pelvic pressure, low back or groin pain, difficult bowel movements, sexual dysfunction, decreased vaginal sensation, and fecal or urinary incontinence (UI).[<xref rid="R3" ref-type="bibr">3</xref>]</p><p>Patients with POP also exhibit symptoms of an overactive bladder (OAB), including daytime frequency or nocturia with urgency and/or urge UI (UUI).[<xref rid="R4" ref-type="bibr">4</xref><xref rid="R5" ref-type="bibr">5</xref><xref rid="R6" ref-type="bibr">6</xref>] One study suggested that over 10% of females experience OAB symptoms regardless of their age.[<xref rid="R7" ref-type="bibr">7</xref>] A recent population-based study reported that 40% of females with POP experienced at least one problematic OAB symptom, and over 80% manifested at least one OAB symptom of any grade,[<xref rid="R8" ref-type="bibr">8</xref>] indicating that OAB and POP symptoms frequently coexist. Although the pathophysiology of OAB is not well elucidated, the integral theory, which underscores structural abnormalities and pelvic floor musculoligamentous system injury as the primary OAB etiology, explains the association between OAB symptoms and POP among hypothesized explanations.[<xref rid="R9" ref-type="bibr">9</xref>] Consequently, OAB symptoms may subside following conservative or surgical therapy for POP.</p><p>The main options for POP treatment comprise surgery, pessary, and pelvic floor exercises. Surgically, in Japan, POP has been mainly treated with laparoscopic or robot-assisted sacrocolpopexy (laparoscopic sacrocolpopexy [LSC]/RSC) and transvaginal mesh surgery (TVM).[<xref rid="R10" ref-type="bibr">10</xref>] For POP repair, a randomized controlled trial comparing LSC with TVM demonstrated that LSC had greater success rates and fewer reoperations than TVM.[<xref rid="R11" ref-type="bibr">11</xref>] LSC provides various benefits as it is associated with a lower incidence of dyspareunia, shorter postoperative hospital stay, faster recovery time, and lower recurrence rate.[<xref rid="R12" ref-type="bibr">12</xref><xref rid="R13" ref-type="bibr">13</xref>] Nonetheless, for the surgical treatment of POP, both techniques seem to have favorable postoperative outcomes.[<xref rid="R10" ref-type="bibr">10</xref><xref rid="R14" ref-type="bibr">14</xref>] However, their effects on postoperative UI remain unknown, particularly when conducted on similar patient groups.</p><p>To date, body mass index (BMI), POP stage, and previous history of laparotomy have been considered in deciding whether to perform LSC or TVM. However, age and diabetes mellitus (DM) should also be considered when comparing urinary storage function following surgeries between these two techniques. Therefore, to reduce possible selection bias caused by the abovementioned factors, we applied propensity score matching analysis (nearest-neighbor propensity score matching). We here aimed to compare the differences in urinary storage conditions following LSC or TVM by eliminating statistical differences as much as possible using propensity score matching analysis.</p></sec><sec sec-type="materials|methods"><title>M<sc>ATERIALS AND</sc> M<sc>ETHODS</sc></title><sec><title>Patients</title><p>We retrospectively reviewed and analyzed clinicopathological data from the medical records of 243 patients with POP who underwent LSC or TVM at our hospital between September 2014 and April 2024. Ninety-six patients underwent LSC and 147 patients received TVM. We examined patients who underwent either surgery within the aforementioned period and followed them for at least 1 year postoperatively at our institution. Indications for surgery included vaginal prolapse symptoms, which meant the POP staging system (POP stage) of &#8805;2.[<xref rid="R15" ref-type="bibr">15</xref>] All procedures performed in this study were in accordance with the tenets of the 2013 revision of the Declaration of Helsinki. The study protocol (Saitama, Japan; ID 4219) was accepted on August 21, 2020, by our institutional ethics committee, and all patients who participated in this study provided written informed consent forms. This study included patients who underwent LSC or TVM for POP within the aforementioned period and excluded those who declined to participate.</p><p>The median follow-up period after surgery was 12.3 months (interquartile range, 12.1&#8211;24.2 months). We recorded types of surgery, age, BMI, the presence of DM, POP stage, previous laparotomy, blood loss, operative time, mesh products used, and intraoperative complications.</p></sec><sec><title>Surgical procedure</title><p>One urologist performed LSC in accordance with the method of Wattiez <italic toggle="yes">et al</italic>.[<xref rid="R16" ref-type="bibr">16</xref>] and our technique. Briefly, following port placement, patients were positioned in a 15&#176; Trendelenburg position to secure a view of the pelvic cavity by shifting the bowel cranially. The following were the significant steps:</p><p>
<list list-type="order"><list-item><p>Anterior vaginal wall dissection: The space between the anterior vaginal wall and bladder was dissected, and anterior wall mesh&#8211;either synthetic polypropylene soft mesh Polyform&#8482; (Boston Scientific Japan, Tokyo, Japan) or polytetrafluoroethylene mesh ORIHIME<sup>&#174;</sup> (Kono Seisakusho, Tokyo, Japan)&#8211;was fixed behind the anterior vaginal wall at the point below the bladder neck</p></list-item><list-item><p>Subtotal hysterectomy and bilateral adnexectomy: These procedures were performed if the uterus and adnexa were present</p></list-item><list-item><p>Posterior vaginal wall dissection: The posterior vaginal wall was separated from the rectum, and posterior wall mesh&#8211;either Polyform&#8482; or ORIHIME<sup>&#174;</sup>&#8211;was fixed to the bilateral puborectalis fascia</p></list-item><list-item><p>The anterior and posterior mesh were fixed to the cervix or vaginal vault</p></list-item><list-item><p>Mesh retroperitonealization: The meshes were covered, and the pelvic peritoneum was partially closed</p></list-item><list-item><p>Peritoneal closure: Following suture fixation of the mesh to the anterior longitudinal ligament at the level of the promontory, the peritoneum was completely closed.</p></list-item></list>
</p><p>Three urologists performed TVM according to the methods described in our previous paper.[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref>] Briefly, the procedure commenced with hydrodissection. Subsequently, the anterior vaginal wall was incised vertically, and the pubocervical fascia was completely dissected laterally using a blunt technique to expose the sacrospinous ligaments. Next, a skin incision was created 4 cm laterally and 3 cm inferior to the anal center. Targeting a position of one or two fingerbreadths medial to the ischial spine, a Shimada needle threaded with 1-0 nylon monofilament sutures was subsequently employed to further penetrate the sacrospinous ligaments from the skin incision. After suture fixation of both ends of the mesh to the vaginal wall behind the bladder neck and to the vaginal wall behind the cervix or vaginal vault, subsequently, the arms of the Polyform&#8482; or ORIHIME<sup>&#174;</sup> mesh were removed using nylon monofilament loops, and an acceptable shape was created, spread, and secured under the bladder. The meshes were cut to fit the stencil paper with two arms in advance. In the Polyform&#8482; group, the mesh arm width was approximately 3 cm. In the ORIHIME<sup>&#174;</sup> group, the initial arm width was cut to 4.5&#8211;6 cm and subsequently increased to approximately 7.5&#8211;8 cm.[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref>] The mesh length behind the bladder was determined by measuring the distance between the cervix or vaginal vault (grasped using Allis forceps) and point Aa (i.e., 3 cm medial to the bladder neck), and then adjusted such that it did not pull the bladder neck excessively in a cephalad direction. Finally, to ensure proper alignment, traction was applied over the externalized arms, and the vaginal wound was closed using 2&#8211;0 Vicryl sutures (Johnson and Johnson, Japan, Tokyo).</p></sec><sec><title>Assessment methods for preoperative and postoperative parameters</title><p>A 60-min pad weight testing was conducted concurrently with the follow-up survey interview to measure UI objectively. Women were requested to use a preweighed extra-long feminine pad. The pad was removed and weighed again after an hour, with the incremental change determined by taking the pad weight after 16 min. This approach is frequently used for pre-and postoperative examinations. To preoperatively and 3&#8211;12 months postoperatively assess the change in overactive bladder symptoms, the overactive bladder symptom score (OABSS) was employed. The International Consultation on Incontinence Questionnaire Short-Form (ICIQ-SF) was also used preoperatively and 3&#8211;12 months postoperatively to assess UI. UI was defined by a daily life disturbance with incontinence regardless of the type of stress UI (SUI), UUI, or mixed UI. Prolapse recurrence was defined as the most dependent portion being at POP stage 2 or further.</p></sec><sec><title>Statistical analysis</title><p>To compare differences in variable data between the LSC and TVM groups before and after propensity score matching, the Kruskal&#8211;Wallis test or unpaired Student&#8217;s <italic toggle="yes">t</italic>-test was employed. Pearson&#8217;s Chi-square test was used for determining differences in the presence of DM; POP stage; mesh used; intraoperative complication rate before and after propensity score matching; and changes in 60-min pad weight, OABSS, ICIQ-SF, prolapse recurrence rate at 1 year postoperatively after propensity score matching between the LSC and TVM groups. Wilcoxon&#8217;s signed&#8211;rank test was performed to compare preoperative and 3&#8211;12-month postoperative 60-min pad weight, OABSS, and ICIQ-SF score within each group. We used age, DM, BMI, POP stage, and number of laparotomies as explanatory variables, which are key factors in investigating the changes in the UI status, to perform a nearest-neighbor propensity score matching. The propensity score for each patient was determined by multiplying each variable (age, DM, BMI, POP stage, and number of laparotomies) by a coefficient that was computed using logistic regression analysis. After performing nearest-neighbor propensity score matching, we compared the surgical outcomes between the matched 67 LSC-treated patients and 67 TVM-treated patients. Statistical analysis was performed using JMP PRO (version 17; SAS Institute, Cary, NC). <italic toggle="yes">P</italic> &lt; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results"><title>R<sc>ESULTS</sc></title><sec><title>Patient parameters</title><p>Before nearest-neighbor propensity score matching, the median age was 74 and 76 years in the LSC and TVM groups, respectively, demonstrating a significant difference (<italic toggle="yes">P</italic> = 0.0303). The mean BMI was 22.6 kg/m<sup>2</sup> in the LSC group and the median BMI was 24.5 kg/m<sup>2</sup> in the TVM group, also exhibiting a significant difference (<italic toggle="yes">P</italic> &lt; 0.0001). Twenty-one and thirteen patients from the LSC and TVM groups, respectively, had stage 4 POP, also showing a significant difference (<italic toggle="yes">P</italic> = 0.0002). Moreover, significant differences in the number of previous laparotomies, blood loss, and operating time were observed between the LSC and TVM groups (<italic toggle="yes">P</italic> = 0.0198, <italic toggle="yes">P</italic> &lt; 0.0001, <italic toggle="yes">P</italic> &lt; 0.0001, respectively). The usage ratio of ORIHIME<sup>&#174;</sup> and Polyform&#8482; was not significantly different between the two groups (<italic toggle="yes">P</italic> = 0.6966). In the LSC group, eight, one, and four patients had anterior vaginal wall, posterior vaginal wall, and bladder injuries, respectively, whereas in the TVM group, two and one patients exhibited peritoneal and bladder injuries, respectively, indicating a significant difference (<italic toggle="yes">P</italic> = 0.0004) [<xref rid="jmh.jmh_106_25-t001" ref-type="table">Table 1</xref>]. However, no serious postoperative complications were observed. All of them were rated as Clavien-Dindo classification grade 1.[<xref rid="R19" ref-type="bibr">19</xref>]</p><table-wrap position="float" id="jmh.jmh_106_25-t001" orientation="portrait"><label>Table 1</label><caption><p>Clinical characteristics of the enrolled patients before matching</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">LSC (<italic toggle="yes">n</italic>=96)</th><th align="center" rowspan="1" colspan="1">TVM (<italic toggle="yes">n</italic>=147)</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (year), median (IQR)</td><td align="center" rowspan="1" colspan="1">74 (70&#8211;78)</td><td align="center" rowspan="1" colspan="1">76 (71&#8211;81)</td><td align="center" rowspan="1" colspan="1">0.0303</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>), mean&#177;SD or median (IQR)</td><td align="center" rowspan="1" colspan="1">22.6&#177;2.4</td><td align="center" rowspan="1" colspan="1">24.5 (22.2&#8211;27.1)</td><td align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">DM, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Present</td><td align="center" rowspan="1" colspan="1">13 (13.5)</td><td align="center" rowspan="1" colspan="1">30 (20.4)</td><td align="center" rowspan="1" colspan="1">0.071</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Absent</td><td align="center" rowspan="1" colspan="1">83 (86.5)</td><td align="center" rowspan="1" colspan="1">117 (79.6)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">POP stage, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Stage 2</td><td align="center" rowspan="1" colspan="1">5 (5.2)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0002</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Stage 3</td><td align="center" rowspan="1" colspan="1">70 (72.9)</td><td align="center" rowspan="1" colspan="1">134 (91.1)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Stage 4</td><td align="center" rowspan="1" colspan="1">21 (21.9)</td><td align="center" rowspan="1" colspan="1">13 (8.9)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Number of previous laparotomies, median (IQR)</td><td align="center" rowspan="1" colspan="1">0 (0&#8211;1)</td><td align="center" rowspan="1" colspan="1">0 (0&#8211;1)</td><td align="center" rowspan="1" colspan="1">0.0198</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood loss (mL), median (IQR)</td><td align="center" rowspan="1" colspan="1">1.0 (0&#8211;7.5)</td><td align="center" rowspan="1" colspan="1">32 (20&#8211;63)</td><td align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Operating time (min), median (IQR)</td><td align="center" rowspan="1" colspan="1">181.5 (151.7&#8211;243.9)</td><td align="center" rowspan="1" colspan="1">64.8 (55.8&#8211;79.2)</td><td align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Mesh used, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;ORIHIME<sup>&#174;</sup></td><td align="center" rowspan="1" colspan="1">67 (69.8)</td><td align="center" rowspan="1" colspan="1">106 (72.1)</td><td align="center" rowspan="1" colspan="1">0.6966</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Polyform&#8482;</td><td align="center" rowspan="1" colspan="1">29 (30.2)</td><td align="center" rowspan="1" colspan="1">41 (27.9)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Intraoperative complications</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Present</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0.0004</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">AVW injury 8</td><td align="center" rowspan="1" colspan="1">Peritoneal injury 2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">PVW injury 1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Bladder injury 4</td><td align="center" rowspan="1" colspan="1">Bladder injury 1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Absent</td><td align="center" rowspan="1" colspan="1">83</td><td align="center" rowspan="1" colspan="1">144</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Values for nonnormally distributed values are expressed as median variables (IQR), and values for normally distributed measurements are expressed as means&#177;SDs. The Kruskal&#8211;Wallis test is employed for determining significant differences in age, BMI, number of previous laparotomies, blood loss, and operating time. Pearson&#8217;s Chi-square test is used for evaluating significant differences in DM, POP stage, mesh products used, and intraoperative complication rate between the LSC and TVM groups. LSC: Laparoscopic sacrocolpopexy, TVM: Transvaginal mesh surgery, IQR: Interquartile range. BMI: Body mass index, SD: Standard deviation, DM: Diabetes mellitus, POP stage: Pelvic organ prolapse stage, AVW: Anterior vaginal wall, PVW: Posterior vaginal wall</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Nearest-neighbor propensity score matching</title><p>We calculated the predicted probability as a propensity score using multiple logistic regression analysis for age, BMI, DM, number of previous laparotomies, and POP stage. We matched 67 pairs between the LSC and TVM groups using nearest-neighbor matching. Following nearest-neighbor propensity score matching, we did not identify any significant differences in age, BMI, DM, POP stage, and number of previous laparotomies between the matched LSC and TVM groups. Significant differences in blood loss, operating time, mesh usage, and intraoperative complication rate still existed even after propensity score matching [<xref rid="jmh.jmh_106_25-t002" ref-type="table">Table 2</xref>].</p><table-wrap position="float" id="jmh.jmh_106_25-t002" orientation="portrait"><label>Table 2</label><caption><p>Clinical characteristics of the matched patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">LSC (<italic toggle="yes">n</italic>=67)</th><th align="center" rowspan="1" colspan="1">TVM (<italic toggle="yes">n</italic>=67)</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (year), mean&#177;SD or median (IQR)</td><td align="center" rowspan="1" colspan="1">74.5&#177;6.3</td><td align="center" rowspan="1" colspan="1">76 (70&#8211;81)</td><td align="center" rowspan="1" colspan="1">0.4827</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>), mean&#177;SD</td><td align="center" rowspan="1" colspan="1">23.2&#177;2.3</td><td align="center" rowspan="1" colspan="1">23.3&#177;3.3</td><td align="center" rowspan="1" colspan="1">0.7816</td></tr><tr><td align="left" rowspan="1" colspan="1">DM, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Present</td><td align="center" rowspan="1" colspan="1">9 (13.4)</td><td align="center" rowspan="1" colspan="1">8 (11.9)</td><td align="center" rowspan="1" colspan="1">0.7952</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Absent</td><td align="center" rowspan="1" colspan="1">58 (86.6)</td><td align="center" rowspan="1" colspan="1">59 (88.1)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">POP stage, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Stage 3</td><td align="center" rowspan="1" colspan="1">57 (85.1)</td><td align="center" rowspan="1" colspan="1">57 (85.1)</td><td align="center" rowspan="1" colspan="1">1.0000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Stage 4</td><td align="center" rowspan="1" colspan="1">10 (14.9)</td><td align="center" rowspan="1" colspan="1">10 (14.9)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Number of previous laparotomies, median (IQR)</td><td align="center" rowspan="1" colspan="1">0 (0&#8211;1)</td><td align="center" rowspan="1" colspan="1">0 (0&#8211;1)</td><td align="center" rowspan="1" colspan="1">0.5953</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood loss (mL), median (IQR)</td><td align="center" rowspan="1" colspan="1">1 (0&#8211;6)</td><td align="center" rowspan="1" colspan="1">30 (16&#8211;56)</td><td align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Operating time (min), median (IQR)</td><td align="center" rowspan="1" colspan="1">195 (153&#8211;270.3)</td><td align="center" rowspan="1" colspan="1">58.8 (55.2&#8211;73.2)</td><td align="center" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Mesh used, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;ORIHIME<sup>&#174;</sup></td><td align="center" rowspan="1" colspan="1">44 (65.7)</td><td align="center" rowspan="1" colspan="1">59 (88.1)</td><td align="center" rowspan="1" colspan="1">0.0021</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Polyform&#8482;</td><td align="center" rowspan="1" colspan="1">23 (34.3)</td><td align="center" rowspan="1" colspan="1">8 (11.9)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Intraoperative complications</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Present</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.0157</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">AVW injury 4</td><td align="center" rowspan="1" colspan="1">Peritoneal injury 1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Bladder injury 4</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Absent</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Values for normally distributed measurements are expressed as means&#177;SDs, and values for nonnormally distributed values are expressed as median variables (IQR). The Kruskal&#8211;Wallis test is employed for determining significant differences in age, number of previous laparotomies, blood loss, and operating time. Student&#8217;s <italic toggle="yes">t</italic>-test is applied for identifying differences in BMI. Pearson&#8217;s Chi-square test is used for evaluating significant differences in DM, POP stage, mesh products used, and intraoperative complication rate between the matched LSC and TVM groups. LSC: laparoscopic sacrocolpopexy, TVM: Transvaginal mesh surgery, SD: Standard deviation, IQR: Interquartile range, BMI: Body mass index, DM: Diabetes mellitus, POP stage: Pelvic organ prolapse stage, AVW: Anterior vaginal wall</p></fn></table-wrap-foot></table-wrap><p>The 60-min pad weight was significantly decreased at 12 and 3&#8211;12 months postoperatively in the matched LSC and TVM groups, respectively, compared with preoperative values [<xref rid="jmh.jmh_106_25-f001" ref-type="fig">Figure 1</xref>]. In both matched groups, the OABSS demonstrated significant changes at 3, 6, and 12 months postoperatively compared with preoperative scores [<xref rid="jmh.jmh_106_25-f002" ref-type="fig">Figure 2a</xref>]. In addition, in both matched groups, the ICIQ-SF scores showed significant changes at 3&#8211;12 months postoperatively compared with preoperative scores [<xref rid="jmh.jmh_106_25-f002" ref-type="fig">Figure 2b</xref>].</p><fig position="float" id="jmh.jmh_106_25-f001" orientation="portrait"><label>Figure 1</label><caption><p>Box plots revealing a significant decrease in the 60-min pad weight at 12 months postoperatively (12 POM) in the matched laparoscopic sacrocolpopexy and at 3&#8211;12 months postoperatively (3&#8211;12 POM) in the matched transvaginal mesh surgery group. **, ***=Significantly different from the condition before surgery (<italic toggle="yes">P</italic> &lt; 0.01, <italic toggle="yes">P</italic> &lt; 0.05, respectively). LSC: Laparoscopic sacrocolpopexy. TVM: Transvaginal mesh surgery</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="JMH-16-301-g001.jpg"/></fig><fig position="float" id="jmh.jmh_106_25-f002" orientation="portrait"><label>Figure 2</label><caption><p>Box plots indicating a significant change in the overactive bladder symptom score (a) and international consultation on incontinence questionnaire short-form (b) at 3&#8211;12 months postoperatively (3&#8211;12 POM) in the matched laparoscopic sacrocolpopexy and transvaginal mesh surgery groups. *, **, ***=Significantly different from the condition before surgery (<italic toggle="yes">P</italic> &lt; 0.001, <italic toggle="yes">P</italic> &lt; 0.01, <italic toggle="yes">P</italic> &lt; 0.05, respectively). OABSS: Overactive bladder symptom score. ICIQ-SF: International Consultation on Incontinence Questionnaire Short-Form. LSC: Laparoscopic sacrocolpopexy. TVM: Transvaginal mesh surgery</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="JMH-16-301-g002.jpg"/></fig><p>Comparing the results at 1 year postoperatively with preoperative values revealed no significant differences in the improvement of 60-min pad weight, OABSS, and ICIQ-SF scores. Moreover, no significant difference in the prolapse recurrence rate at 12 months postoperatively was noted between the matched LSC and TVM groups [<xref rid="jmh.jmh_106_25-t003" ref-type="table">Table 3</xref>]. In addition, the rate of mesh exposure was only observed in one case in the matched TVM group.</p><table-wrap position="float" id="jmh.jmh_106_25-t003" orientation="portrait"><label>Table 3</label><caption><p>Association between surgical methods and postoperative results at 1 year compared to preoperative conditions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">LSC (<italic toggle="yes">n</italic>=67), <italic toggle="yes">n</italic> (%)</th><th align="center" rowspan="1" colspan="1">TVM (<italic toggle="yes">n</italic>=67), <italic toggle="yes">n</italic> (%)</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">60-min pad test</td><td align="center" rowspan="1" colspan="1"><italic toggle="yes">n</italic>=64</td><td align="center" rowspan="1" colspan="1"><italic toggle="yes">n</italic>=47</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Worse</td><td align="center" rowspan="1" colspan="1">11 (17.2)</td><td align="center" rowspan="1" colspan="1">13 (27.7)</td><td align="center" rowspan="1" colspan="1">0.1854</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Better or no change</td><td align="center" rowspan="1" colspan="1">53 (82.8)</td><td align="center" rowspan="1" colspan="1">34 (72.3)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">OABSS</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Worse</td><td align="center" rowspan="1" colspan="1">14 (20.9)</td><td align="center" rowspan="1" colspan="1">12 (17.9)</td><td align="center" rowspan="1" colspan="1">0.6622</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Better or no change</td><td align="center" rowspan="1" colspan="1">53 (79.1)</td><td align="center" rowspan="1" colspan="1">55 (82.1)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ICIQ-SF</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Worse</td><td align="center" rowspan="1" colspan="1">10 (14.9)</td><td align="center" rowspan="1" colspan="1">10 (14.9)</td><td align="center" rowspan="1" colspan="1">1.0000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Better or no change</td><td align="center" rowspan="1" colspan="1">57 (85.1)</td><td align="center" rowspan="1" colspan="1">57 (85.1)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Prolapse recurrence</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Present</td><td align="center" rowspan="1" colspan="1">4 (6.0)</td><td align="center" rowspan="1" colspan="1">3 (4.5)</td><td align="center" rowspan="1" colspan="1">0.6978</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Absent</td><td align="center" rowspan="1" colspan="1">63 (94.0)</td><td align="center" rowspan="1" colspan="1">64 (95.5)</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Pearson&#8217;s Chi-squared test is employed for evaluating significant differences in improvements in 60-min pad weight, OABSS, ICIQ-SF, and prolapse recurrence rate at 12 months postoperatively. LSC: Laparoscopic sacrocolpopexy, TVM: Transvaginal mesh surgery, OABSS: Overactive bladder symptom score, ICIQ-SF: International consultation on Incontinence Questionnaire Short Form</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>D<sc>ISCUSSION</sc></title><p>This study demonstrated significant differences in age, BMI, DM, POP stage, and number of previous laparotomies between the LSC and TVM groups before nearest-neighbor propensity score matching analysis. However, no significant differences in the aforementioned factors were observed between the two groups after making matched pairs. We noted significant differences in blood loss, operating time, and intraoperative complication rate between the matched LSC and TVM groups even after matching. Following propensity score matching, the OABSS and ICIQ-SF score significantly decreased at 3, 6, and 12 months postoperatively in the matched LSC and TVM groups. Conversely, the 60-min pad weight significantly decreased at 12 and 3&#8211;12 months following LSC and TVM, respectively. Moreover, no significant differences in improvements in the 60-min pad weight, OABSS, and ICIQ-SF scores compared with preoperative values were found, and the matched LSC and TVM groups exhibited no significant difference in prolapse recurrence rates.</p><p>POP surgery may improve SUI and/or UUI; however, it may also expose UI that POP had previously concealed.[<xref rid="R20" ref-type="bibr">20</xref>] Anatomical misalignment following POP repair surgery may result in postoperative UI. Increased mesh tension or overcorrection may cause urethral or bladder neck shifting, which could cause <italic toggle="yes">de novo</italic> or exacerbated SUI. Increased urethral mobility or bladder outflow restriction may result from this misalignment, which can also affect the urethral closure process. During POP repair surgery, cystoscopic observations showed aberrant tension along the trigone and posterior wall owing to mesh traction, as well as bladder neck opening.[<xref rid="R21" ref-type="bibr">21</xref>] Furthermore, considering that maximal urethral closure pressure may decline postoperatively, some studies have suggested that LSC cannot manage functional sphincter deficits.[<xref rid="R22" ref-type="bibr">22</xref>] To prevent overcorrection, careful intraoperative adjustments are necessary, and postoperative monitoring is crucial to determine whether the anatomical realignment affects continence outcomes.[<xref rid="R23" ref-type="bibr">23</xref>]</p><p>On April 16, 2019, the Food and Drug Administration ordered all TVM manufacturers to cease selling synthetic mesh used for anterior compartment prolapse transvaginal repair because they failed to provide a reasonable assurance of safety and efficacy.[<xref rid="R24" ref-type="bibr">24</xref>] Previous studies have indicated that the TVM group demonstrated a higher SUI incidence than the LSC and RSC groups.[<xref rid="R25" ref-type="bibr">25</xref><xref rid="R26" ref-type="bibr">26</xref>] Nonetheless, in Japan, TVM has demonstrated positive results, including a low incidence of mesh-related issues, including UI, and a low incidence of prolapse recurrence postoperatively.[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R27" ref-type="bibr">27</xref><xref rid="R28" ref-type="bibr">28</xref><xref rid="R29" ref-type="bibr">29</xref>] Using a minimal mesh has previously been recommended for POP treatment;[<xref rid="R28" ref-type="bibr">28</xref>] however, based on our previous study, we advise TVM employing ORIHIME<sup>&#174;</sup> with wide arms and adjustable length beneath the bladder.[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref><xref rid="R27" ref-type="bibr">27</xref>] The higher postoperative UI rate in the group where the mesh length beneath the bladder was not adjusted also aligns with the results of several studies indicating that postoperative SUI is caused by bladder neck overcorrection, urethral supporting deficiencies, and neural denervation.[<xref rid="R30" ref-type="bibr">30</xref><xref rid="R31" ref-type="bibr">31</xref><xref rid="R32" ref-type="bibr">32</xref>]</p><p>POP and OAB symptoms causing UI are two distinct pelvic floor disorders that can occur in the same patient. A previous study reported that POP was strongly correlated with OAB symptoms.[<xref rid="R33" ref-type="bibr">33</xref>] Patients with POP symptoms should be evaluated for the presence or absence of OAB symptoms to appropriately manage their symptoms. In addition to evaluating symptoms and determining how they impact the quality of life, a focused physical examination is essential, emphasizing on genitourinary examination and prolapse severity. This procedure should result in appropriate treatment aims through clinical decision-making techniques and trustworthy preoperative counseling.[<xref rid="R33" ref-type="bibr">33</xref>] OAB symptoms should be assessed in females with POP, and patient-reported outcome measures, including the OABSS or ICIQ-SF, should be employed for estimating the degree of UI-related discomfort.[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref>]</p><p>Using nearest-neighbor propensity score matching analysis, we evaluated postoperative outcomes among LSC-or TVM-treated patients who had comparable preoperative factors. As long as the patient&#8217;s performance status is acceptable, BMI, history of previous laparotomies, and POP stage are used to determine whether LSC or TVM should be performed at our institution. However, age and DM should also be added along with the aforementioned factors as explanatory factors in the nearest-neighbor propensity score matching analysis to compare postoperative storage conditions. We believe that the matched LSC and TVM groups can be compared without possible statistical biases.</p><p>This study has several limitations. It was a retrospective study, not a prospective one, conducted at a single center, and our sample size was relatively small, which may limit the generalizability of the findings. Moreover, the median follow-up period postoperatively was relatively short. However, a postoperative follow-up period of at least &gt;1 year would be considered sufficient for patients with benign diseases, including POP; however, we believe that multicenter studies with larger sample sizes and longer follow-up duration would validate our findings and strengthen the evidence level.</p></sec><sec sec-type="conclusion"><title>C<sc>ONCLUSION</sc></title><p>Based on the nearest-neighbor propensity score matching analysis, TVM and LSC may be effective for ameliorating UI-related symptoms postoperatively. However, TVM may be a more favorable option for managing all types of POP than LSC, considering its shorter operative time and lower complication rate.</p><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>R<sc>EFERENCES</sc></title><ref id="R1"><label>1</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Haylen</surname><given-names>BT</given-names></name><name name-style="western"><surname>de</surname><given-names>Ridder D</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>RM</given-names></name><name name-style="western"><surname>Swift</surname><given-names>SE</given-names></name><name name-style="western"><surname>Berghmans</surname><given-names>B</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><etal/></person-group><article-title>An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction</article-title><source>Int Urogynecol J</source><year>2010</year><volume>21</volume><fpage>5</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">19937315</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00192-009-0976-9</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Barber</surname><given-names>MD</given-names></name><name name-style="western"><surname>Maher</surname><given-names>C</given-names></name></person-group><article-title>Epidemiology and outcome assessment of pelvic organ prolapse</article-title><source>Int Urogynecol J</source><year>2013</year><volume>24</volume><fpage>1783</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">24142054</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00192-013-2169-9</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Roos</surname><given-names>AM</given-names></name><name name-style="western"><surname>Thakar</surname><given-names>R</given-names></name><name name-style="western"><surname>Sultan</surname><given-names>AH</given-names></name><name name-style="western"><surname>Burger</surname><given-names>CW</given-names></name><name name-style="western"><surname>Paulus</surname><given-names>AT</given-names></name></person-group><article-title>Pelvic floor dysfunction: Women's sexual concerns unraveled</article-title><source>J Sex Med</source><year>2014</year><volume>11</volume><fpage>743</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">23347592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jsm.12070</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Haylen</surname><given-names>BT</given-names></name><name name-style="western"><surname>Maher</surname><given-names>CF</given-names></name><name name-style="western"><surname>Barber</surname><given-names>MD</given-names></name><name name-style="western"><surname>Camargo</surname><given-names>S</given-names></name><name name-style="western"><surname>Dandolu</surname><given-names>V</given-names></name><name name-style="western"><surname>Digesu</surname><given-names>A</given-names></name><etal/></person-group><article-title>An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP)</article-title><source>Int Urogynecol J</source><year>2016</year><volume>27</volume><fpage>655</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">26984443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00192-016-3003-y</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Drake</surname><given-names>MJ</given-names></name></person-group><article-title>Fundamentals of terminology in lower urinary tract function</article-title><source>Neurourol Urodyn</source><year>2018</year><volume>37</volume><fpage>S13</fpage><lpage>9</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/nau.23768</pub-id><pub-id pub-id-type="pmid">30614063</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Holman</surname><given-names>CD</given-names></name><name name-style="western"><surname>Moorin</surname><given-names>RE</given-names></name><name name-style="western"><surname>Tsokos</surname><given-names>N</given-names></name></person-group><article-title>Lifetime risk of undergoing surgery for pelvic organ prolapse</article-title><source>Obstet Gynecol</source><year>2010</year><volume>116</volume><fpage>1096</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">20966694</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AOG.0b013e3181f73729</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Irwin</surname><given-names>DE</given-names></name><name name-style="western"><surname>Milsom</surname><given-names>I</given-names></name><name name-style="western"><surname>Hunskaar</surname><given-names>S</given-names></name><name name-style="western"><surname>Reilly</surname><given-names>K</given-names></name><name name-style="western"><surname>Kopp</surname><given-names>Z</given-names></name><name name-style="western"><surname>Herschorn</surname><given-names>S</given-names></name><etal/></person-group><article-title>Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study</article-title><source>Eur Urol</source><year>2006</year><volume>50</volume><fpage>1306</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">17049716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eururo.2006.09.019</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Karjalainen</surname><given-names>PK</given-names></name><name name-style="western"><surname>Tolppanen</surname><given-names>AM</given-names></name><name name-style="western"><surname>Mattsson</surname><given-names>NK</given-names></name><name name-style="western"><surname>Wihersaari</surname><given-names>OA</given-names></name><name name-style="western"><surname>Jalkanen</surname><given-names>JT</given-names></name><name name-style="western"><surname>Nieminen</surname><given-names>K</given-names></name></person-group><article-title>Pelvic organ prolapse surgery and overactive bladder symptoms-a population-based cohort (FINPOP)</article-title><source>Int Urogynecol J</source><year>2022</year><volume>33</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">34245317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00192-021-04920-w</pub-id><pub-id pub-id-type="pmcid">PMC8739293</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Petros</surname><given-names>PE</given-names></name><name name-style="western"><surname>Ulmsten</surname><given-names>UI</given-names></name></person-group><article-title>An integral theory of female urinary incontinence. Experimental and clinical considerations</article-title><source>Acta Obstet Gynecol Scand Suppl</source><year>1990</year><volume>153</volume><fpage>7</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">2093278</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0412.1990.tb08027.x</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Obinata</surname><given-names>D</given-names></name><name name-style="western"><surname>Sugihara</surname><given-names>T</given-names></name><name name-style="western"><surname>Yasunaga</surname><given-names>H</given-names></name><name name-style="western"><surname>Mochida</surname><given-names>J</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Murata</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Tension-free vaginal mesh surgery versus laparoscopic sacrocolpopexy for pelvic organ prolapse: Analysis of perioperative outcomes using a Japanese national inpatient database</article-title><source>Int J Urol</source><year>2018</year><volume>25</volume><fpage>655</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">29729035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/iju.13587</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Maher</surname><given-names>CF</given-names></name><name name-style="western"><surname>Feiner</surname><given-names>B</given-names></name><name name-style="western"><surname>DeCuyper</surname><given-names>EM</given-names></name><name name-style="western"><surname>Nichlos</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Hickey</surname><given-names>KV</given-names></name><name name-style="western"><surname>O&#8217;Rourke</surname><given-names>P</given-names></name></person-group><article-title>Laparoscopic sacral colpopexy versus total vaginal mesh for vaginal vault prolapse: A randomized trial</article-title><source>Am J Obstet Gynecol</source><year>2011</year><volume>204</volume><fpage>360.e1</fpage><lpage>7</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2010.11.016</pub-id><pub-id pub-id-type="pmid">21306698</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Rivoire</surname><given-names>C</given-names></name><name name-style="western"><surname>Botchorishvili</surname><given-names>R</given-names></name><name name-style="western"><surname>Canis</surname><given-names>M</given-names></name><name name-style="western"><surname>Jardon</surname><given-names>K</given-names></name><name name-style="western"><surname>Rabischong</surname><given-names>B</given-names></name><name name-style="western"><surname>Wattiez</surname><given-names>A</given-names></name><etal/></person-group><article-title>Complete laparoscopic treatment of genital prolapse with meshes including vaginal promontofixation and anterior repair: A series of 138 patients</article-title><source>J Minim Invasive Gynecol</source><year>2007</year><volume>14</volume><fpage>712</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17980331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmig.2007.06.017</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Maher</surname><given-names>C</given-names></name><name name-style="western"><surname>Feiner</surname><given-names>B</given-names></name><name name-style="western"><surname>Baessler</surname><given-names>K</given-names></name><name name-style="western"><surname>Schmid</surname><given-names>C</given-names></name></person-group><article-title>Surgical management of pelvic organ prolapse in women</article-title><source>Cochrane Database Syst Rev</source><year>2013</year><volume>30</volume><fpage>CD004014</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD004014.pub5</pub-id><pub-id pub-id-type="pmid">23633316</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Niu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name></person-group><article-title>Comparison between laparoscopic uterus/sacrocolpopexy and total pelvic floor reconstruction with vaginal mesh for the treatment of pelvic organ prolapse</article-title><source>J Obstet Gynaecol Res</source><year>2019</year><volume>45</volume><fpage>915</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">30652385</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jog.13908</pub-id><pub-id pub-id-type="pmcid">PMC6590650</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Bland</surname><given-names>DR</given-names></name><name name-style="western"><surname>Earle</surname><given-names>BB</given-names></name><name name-style="western"><surname>Vitolins</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Burke</surname><given-names>G</given-names></name></person-group><article-title>Use of the pelvic organ prolapse staging system of the International Continence Society, American Urogynecologic Society, and Society of Gynecologic Surgeons in perimenopausal women</article-title><source>Am J Obstet Gynecol</source><year>1999</year><volume>181</volume><fpage>1324</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10601907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0002-9378(99)70371-6</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Wattiez</surname><given-names>A</given-names></name><name name-style="western"><surname>Boughizane</surname><given-names>S</given-names></name><name name-style="western"><surname>Alexandre</surname><given-names>F</given-names></name><name name-style="western"><surname>Canis</surname><given-names>M</given-names></name><name name-style="western"><surname>Mage</surname><given-names>G</given-names></name><name name-style="western"><surname>Pouly</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Laparoscopic procedures for stress incontinence and prolapse</article-title><source>Curr Opin Obstet Gynecol</source><year>1995</year><volume>7</volume><fpage>317</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">7578974</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Kuroda</surname><given-names>K</given-names></name><name name-style="western"><surname>Hamamoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Kawamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Masunaga</surname><given-names>A</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>H</given-names></name><name name-style="western"><surname>Horiguchi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Favorable postoperative outcomes after transvaginal mesh surgery using a wide-arm ORIHIME&#174;mesh</article-title><source>Cureus</source><year>2024</year><volume>16</volume><fpage>e53388</fpage><pub-id pub-id-type="pmid">38435168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.53388</pub-id><pub-id pub-id-type="pmcid">PMC10908251</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Kuroda</surname><given-names>K</given-names></name><name name-style="western"><surname>Hamamoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Kawamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>H</given-names></name><name name-style="western"><surname>Horiguchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Ito</surname><given-names>K</given-names></name></person-group><article-title>Efficacy of transvaginal surgery using an ORIHIME mesh with wider arms and adjusted length</article-title><source>Cureus</source><year>2024</year><volume>16</volume><fpage>e57106</fpage><pub-id pub-id-type="pmid">38681380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.57106</pub-id><pub-id pub-id-type="pmcid">PMC11055613</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Clavien</surname><given-names>PA</given-names></name><name name-style="western"><surname>Barkun</surname><given-names>J</given-names></name><name name-style="western"><surname>de</surname><given-names>Oliveira ML</given-names></name><name name-style="western"><surname>Vauthey</surname><given-names>JN</given-names></name><name name-style="western"><surname>Dindo</surname><given-names>D</given-names></name><name name-style="western"><surname>Schulick</surname><given-names>RD</given-names></name><etal/></person-group><article-title>The Clavien-Dindo classification of surgical complications: Five-year experience</article-title><source>Ann Surg</source><year>2009</year><volume>250</volume><fpage>187</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">19638912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0b013e3181b13ca2</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Lensen</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Withagen</surname><given-names>MI</given-names></name><name name-style="western"><surname>Kluivers</surname><given-names>KB</given-names></name><name name-style="western"><surname>Milani</surname><given-names>AL</given-names></name><name name-style="western"><surname>Vierhout</surname><given-names>ME</given-names></name></person-group><article-title>Urinary incontinence after surgery for pelvic organ prolapse</article-title><source>Neurourol Urodyn</source><year>2013</year><volume>32</volume><fpage>455</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23024012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/nau.22327</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Nomura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Okada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hiramatsu</surname><given-names>A</given-names></name><name name-style="western"><surname>Matsubara</surname><given-names>E</given-names></name><name name-style="western"><surname>Kato</surname><given-names>K</given-names></name><name name-style="western"><surname>Yoshimura</surname><given-names>Y</given-names></name></person-group><article-title>A new method of adjusting mesh tension using cystoscopy during laparoscopic sacrocolpopexy</article-title><source>Int Urogynecol J</source><year>2021</year><volume>32</volume><fpage>3089</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">33871668</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00192-021-04791-1</pub-id><pub-id pub-id-type="pmcid">PMC8536586</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>HH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>WC</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>YW</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Su</surname><given-names>TH</given-names></name></person-group><article-title>Changes in urodynamic measurements and bladder neck position after single-incision trans-vaginal mesh for pelvic organ prolapse</article-title><source>Int Urogynecol J</source><year>2015</year><volume>26</volume><fpage>1629</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">26156205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00192-015-2753-2</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Nygaard</surname><given-names>IE</given-names></name><name name-style="western"><surname>Heit</surname><given-names>M</given-names></name></person-group><article-title>Stress urinary incontinence</article-title><source>Obstet Gynecol</source><year>2004</year><volume>104</volume><fpage>607</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">15339776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.AOG.0000137874.84862.94</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="webpage" publication-format="web"><collab>U. S. Food and Drug Administration</collab><article-title>Urogynecologic Surgical Mesh Implants</article-title><comment>Available from:<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.fda.gov/medical-devices/implants-and-prosthetics/urogynecologic-surgical-mesh-implants">https://www.fda.gov/medical-devices/implants-and-prosthetics/urogynecologic-surgical-mesh-implants</uri></comment><date-in-citation>Last accessed on 2024 Oct 01</date-in-citation></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>CK</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>CP</given-names></name><name name-style="western"><surname>Chou</surname><given-names>MM</given-names></name><name name-style="western"><surname>Shen</surname><given-names>PS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>GD</given-names></name><name name-style="western"><surname>Hung</surname><given-names>YC</given-names></name><etal/></person-group><article-title>A comparative study of laparoscopic sacrocolpopexy and total vaginal mesh procedure using lightweight polypropylene meshes for prolapse repair</article-title><source>Taiwan J Obstet Gynecol</source><year>2014</year><volume>53</volume><fpage>552</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">25510700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tjog.2014.07.006</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Kusuda</surname><given-names>M</given-names></name><name name-style="western"><surname>Kagami</surname><given-names>K</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>I</given-names></name><name name-style="western"><surname>Nozaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>I</given-names></name></person-group><article-title>Comparison of transvaginal mesh surgery and robot-assisted sacrocolpopexy for pelvic organ prolapse</article-title><source>BMC Surg</source><year>2022</year><volume>22</volume><fpage>268</fpage><pub-id pub-id-type="pmid">35820857</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12893-022-01702-z</pub-id><pub-id pub-id-type="pmcid">PMC9275127</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Kuroda</surname><given-names>K</given-names></name><name name-style="western"><surname>Hamamoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Kawamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Horiguchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Ito</surname><given-names>K</given-names></name></person-group><article-title>Comparison between the effect of transvaginal mesh surgery using Orihime(&#174;) mesh and laparoscopic sacrocolpopexy at 1 year postoperatively -TVM has a favorable postoperative course compared to LSC in patients with pop scored &#8804;stage 3</article-title><source>Nihon Hinyokika Gakkai Zasshi</source><year>2024</year><volume>115</volume><fpage>53</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">40254452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5980/jpnjurol.115.53</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Takazawa</surname><given-names>N</given-names></name><name name-style="western"><surname>Fujisaki</surname><given-names>A</given-names></name><name name-style="western"><surname>Yoshimura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tsujimura</surname><given-names>A</given-names></name><name name-style="western"><surname>Horie</surname><given-names>S</given-names></name></person-group><article-title>Short-term outcomes of the transvaginal minimal mesh procedure for pelvic organ prolapse</article-title><source>Investig Clin Urol</source><year>2018</year><volume>59</volume><fpage>133</fpage><lpage>40</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.4111/icu.2018.59.2.133</pub-id><pub-id pub-id-type="pmcid">PMC5840118</pub-id><pub-id pub-id-type="pmid">29520390</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>S</given-names></name><name name-style="western"><surname>Obinata</surname><given-names>D</given-names></name><name name-style="western"><surname>Sakuma</surname><given-names>T</given-names></name><name name-style="western"><surname>Nagane</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sato</surname><given-names>K</given-names></name><name name-style="western"><surname>Mochida</surname><given-names>J</given-names></name><etal/></person-group><article-title>Tension-free vaginal mesh procedure for pelvic organ prolapse: A single-center experience of 310 cases with 1-year follow up</article-title><source>Int J Urol</source><year>2010</year><volume>17</volume><fpage>353</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20202001</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1442-2042.2010.02469.x</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Oride</surname><given-names>A</given-names></name><name name-style="western"><surname>Kanasaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Hara</surname><given-names>T</given-names></name><name name-style="western"><surname>Kyo</surname><given-names>S</given-names></name></person-group><article-title>Postoperative outcomes following tension-free vaginal mesh surgery for pelvic organ prolapse: A retrospective study</article-title><source>Urol J</source><year>2019</year><volume>16</volume><fpage>581</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">31630387</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.22037/uj.v0i0.4631</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Lo</surname><given-names>TS</given-names></name><name name-style="western"><surname>Bt</surname><given-names>Karim N</given-names></name><name name-style="western"><surname>Cortes</surname><given-names>EF</given-names></name><name name-style="western"><surname>Wu</surname><given-names>PY</given-names></name><name name-style="western"><surname>Lin</surname><given-names>YH</given-names></name><name name-style="western"><surname>Tan</surname><given-names>YL</given-names></name></person-group><article-title>Comparison between elevate anterior/apical system and Perigee system in pelvic organ prolapse surgery: Clinical and sonographic outcomes</article-title><source>Int Urogynecol J</source><year>2015</year><volume>26</volume><fpage>391</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">25257810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00192-014-2492-9</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Lin</surname><given-names>YH</given-names></name><name name-style="western"><surname>Chang</surname><given-names>YL</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SD</given-names></name></person-group><article-title>Urodynamic and clinical effects of transvaginal mesh repair for severe cystocele with and without urinary incontinence</article-title><source>Int J Gynaecol Obstet</source><year>2011</year><volume>112</volume><fpage>182</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">21238966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijgo.2010.09.011</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Aimjirakul</surname><given-names>K</given-names></name><name name-style="western"><surname>Ng</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Saraluck</surname><given-names>A</given-names></name><name name-style="western"><surname>Wattanayingcharoenchai</surname><given-names>R</given-names></name><name name-style="western"><surname>Mangmeesri</surname><given-names>P</given-names></name><name name-style="western"><surname>Manonai</surname><given-names>J</given-names></name></person-group><article-title>A retrospective cohort study on the prevalence, risk factors, and improvement of overactive bladder symptoms in women with pelvic organ prolapse</article-title><source>Int J Womens Health</source><year>2023</year><volume>15</volume><fpage>1039</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">37469654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJWH.S413670</pub-id><pub-id pub-id-type="pmcid">PMC10352122</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>